Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Plos One|April 18, 2012
A common role for various human truncated adenomatous polyposis coli isoforms in the control of beta-catenin activity and cell proliferationShree Harsha Vijaya Chandra, Ingrid Wacker, Uwe Kurt Appelt, et al.Cells|January 11, 2024
CREB Is Indispensable to KIT Function in Human Skin Mast Cells-A Positive Feedback Loop between CREB and KIT Orchestrates Skin Mast Cell FateGürkan Bal, Jean Schneikert, Zhuoran Li, et al.Cells|October 25, 2024
CREB Is Critically Implicated in Skin Mast Cell Degranulation Elicited via FcεRI and MRGPRX2Zhuoran Li, Jean Schneikert, Shiva Raj Tripathi, et al.Plos One|July 11, 2013
Functional comparison of human adenomatous polyposis coli (APC) and APC-like in targeting beta-catenin for degradationJean Schneikert, Shree Harsha Vijaya Chandra, Jan Gustav Ruppert, et al.Proceedings of the National Academy of Sciences of the United States of America|October 16, 2019
Loss of p53 function at late stages of tumorigenesis confers ARF-dependent vulnerability to p53 reactivation therapyBoris Klimovich, Samet Mutlu, Jean Schneikert, et al.The EMBO Journal|February 10, 2011
Amer1/WTX couples Wnt-induced formation of PtdIns(4,5)P2 to LRP6 phosphorylationKristina Tanneberger, Astrid S Pfister, Katharina Brauburger, et al.Nature Communications|September 18, 2020
mTOR-mediated cancer drug resistance suppresses autophagy and generates a druggable metabolic vulnerabilityNiklas Gremke, Pierfrancesco Polo, Aaron Dort, et al.Cancer Research|September 3, 2020
Phosphorylation Control of p53 DNA-Binding Cooperativity Balances Tumorigenesis and AgingOleg Timofeev, Lukas Koch, Constantin Niederau, et al.Nature Chemical Biology|November 24, 2015
CRISPR-Cas9-based target validation for p53-reactivating model compoundsMichael Wanzel, Jonas B Vischedyk, Miriam P Gittler, et al.The EMBO Journal|September 5, 2019
Residual apoptotic activity of a tumorigenic p53 mutant improves cancer therapy responsesOleg Timofeev, Boris Klimovich, Jean Schneikert, et al.Pageof 3